Overview

About Genta

Genta Iwasaki is an associate who focuses his practice on health care law. Genta has experience advising physician groups, independent physician associations, private equities investing in the health care space, pharmacies and other health care entities in mergers and acquisitions, operational and contracting matters, and general corporate counsel matters. Earlier in his career, he counseled Japanese corporations on their major U.S. mergers and acquisitions, investments and general corporate governance issues owing to his bilingualism.

Before joining Stoel Rives, Genta was an associate with Sheppard, Mullin, Richter & Hampton LLP (2020–2022) and with Alston & Bird (2017–2020).

Expand to Read More + See Less -

Experience

Represented leading NYC-based private equity group in its strategic partnership with another private equity group and agreement to acquire a majority interest in a leading provider of hub services for patients and providers in the health care space.
Represented multi-state provider of home oxygen and respiratory therapy in its ongoing limited sale process to various bidders.
Represented a Japanese industrial gas, chemical, medical, energy, and agriculture and food products company in connection with an $133 million reverse triangular merger with a manufacturer of carbon dioxide-related equipment based in Georgia.
Represented a Japanese insurance company in connection with an $8 million stock purchase acquisition of an insurance broker focusing on property/casualty and employee benefits insurance based in California.
Represented a Japanese conglomerate in connection with an option to purchase an additional 17.45% equity ownership on a fully diluted, as-converted basis of an animal pharmaceutical development and marketing company based in North Carolina.

Expand to Read More + See Less -

Honors

Honors & Activities

Civic Activities

Past Atlanta chapter ambassador for Aging2.0, a global innovation platform focused on connecting and supporting entrepreneurs in the aging field (2018–2019)

Expand to Read More + See Less -